303 related articles for article (PubMed ID: 18549626)
61. Prognostic impact of concordant and discordant bone marrow involvement and cell-of-origin in Korean patients with diffuse large B-cell lymphoma treated with R-CHOP.
Park MJ; Park SH; Park PW; Seo YH; Kim KH; Seo JY; Jeong JH; Kim MJ; Ahn JY; Hong J
J Clin Pathol; 2015 Sep; 68(9):733-8. PubMed ID: 25998512
[TBL] [Abstract][Full Text] [Related]
62. [Expression of CD147 and matrix metalloproteinase-9 in children with non-Hodgkin's lymphoma and its correlation with prognosis].
Liu AG; Hu Q; Tao HF; Liu SY; Zhang LQ; Hu Y
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):785-8. PubMed ID: 20021816
[TBL] [Abstract][Full Text] [Related]
63. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
Sasaki K; Niitsu N
Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
[TBL] [Abstract][Full Text] [Related]
64. [Value of Multiparameter Flow Cytometry in Diagnosis of Non-Hodgkin's Lymphoma].
Li YP; Zhang ZH; Zhao FT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):102-5. PubMed ID: 26913403
[TBL] [Abstract][Full Text] [Related]
65. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
[TBL] [Abstract][Full Text] [Related]
66. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.
Bennett JM; Cain KC; Glick JH; Johnson GJ; Ezdinli E; O'Connell MJ
J Clin Oncol; 1986 Oct; 4(10):1462-9. PubMed ID: 3531421
[TBL] [Abstract][Full Text] [Related]
67. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
Cairo MS; Sposto R; Gerrard M; Auperin A; Goldman SC; Harrison L; Pinkerton R; Raphael M; McCarthy K; Perkins SL; Patte C
J Clin Oncol; 2012 Feb; 30(4):387-93. PubMed ID: 22215753
[TBL] [Abstract][Full Text] [Related]
68. T-cell rich B-cell lymphoma: clinical distinctiveness and response to treatment in 45 patients.
Ripp JA; Loiue DC; Chan W; Nawaz H; Portlock CS
Leuk Lymphoma; 2002 Aug; 43(8):1573-80. PubMed ID: 12400599
[TBL] [Abstract][Full Text] [Related]
69. Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.
Lu R; Jiang M; Chen Z; Xu X; Hu H; Zhao X; Gao X; Guo L
PLoS One; 2013; 8(9):e74853. PubMed ID: 24086384
[TBL] [Abstract][Full Text] [Related]
70. Correlation between peripheral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma.
Lin H; Sun XF; Zhen ZJ; Xia Y; Ling JY; Huang HQ; Xia ZJ; Lin TY
Ai Zheng; 2009 Nov; 28(11):1186-92. PubMed ID: 19895740
[TBL] [Abstract][Full Text] [Related]
71. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
[TBL] [Abstract][Full Text] [Related]
72. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL).
Kim SJ; Choi CW; Mun YC; Oh SY; Kang HJ; Lee SI; Won JH; Kim MK; Kwon JH; Kim JS; Kwak JY; Kwon JM; Hwang IG; Kim HJ; Lee JH; Oh S; Park KW; Suh C; Kim WS
BMC Cancer; 2011 Jul; 11():321. PubMed ID: 21798075
[TBL] [Abstract][Full Text] [Related]
73. Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma.
Yan Y; Chan WC; Weisenburger DD; Anderson JR; Bast MA; Vose JM; Bierman PJ; Armitage JO
J Clin Oncol; 1995 Jun; 13(6):1336-42. PubMed ID: 7751877
[TBL] [Abstract][Full Text] [Related]
74. [Detection of bone marrow involvement by lymphoma cells in patients with B-NHL by using flow cytometry analysis].
Wang W; Gao L; Wang LL; Li MY; Li YY; Zhao W; Xu YY; Ding Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1204-7. PubMed ID: 21129261
[TBL] [Abstract][Full Text] [Related]
75. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.
Guney N; Soydinc HO; Basaran M; Bavbek S; Derin D; Camlica H; Yasasever V; Topuz E
Asian Pac J Cancer Prev; 2009; 10(4):669-74. PubMed ID: 19827892
[TBL] [Abstract][Full Text] [Related]
76. [Outcomes of 104 children with B-cell non-Hodgkin lymphoma].
Ye QD; Pan C; Xue HL; Chen J; Zhou M; Jiang H; Shen SH; Tang YJ; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):399-403. PubMed ID: 23688749
[TBL] [Abstract][Full Text] [Related]
77. The clinical value of follow-up examinations in childhood T-cell acute lymphoblastic leukemia and T-cell non-Hodgkin's lymphoma.
Huang L; Lequin M; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2007 Apr; 48(4):468-72. PubMed ID: 16514610
[TBL] [Abstract][Full Text] [Related]
78. Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience.
Ko OB; Lee DH; Kim SW; Lee JS; Kim S; Huh J; Suh C
Korean J Intern Med; 2009 Jun; 24(2):128-34. PubMed ID: 19543491
[TBL] [Abstract][Full Text] [Related]
79. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis.
Huang DY; Hu YF; Wei N; Fu L; Wu L; Shen J; Wang JS; Wang Z
Chin Med J (Engl); 2019 Feb; 132(3):294-301. PubMed ID: 30681495
[TBL] [Abstract][Full Text] [Related]
80. [Detection of gene rearrangement in bone marrow of patients with non Hodgkin's lymphoma by BIOMED-2 protocols].
Tong Y; Qiao C; Wu RQ; Liu P; Zhou X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1409-14. PubMed ID: 22169293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
